Chimin Health Management Co (SHSE:603222) ROCE % : 5.04% (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Chimin Health Management Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Chimin Health Management Co's annualized ROCE % for the quarter that ended in Mar. 2024 was 5.04%.

Chimin Health Management Co ROCE % Historical Data

The historical data trend for Chimin Health Management Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chimin Health Management Co ROCE % Chart

Chimin Health Management Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

8.70

3.31

14.00

3.69

-1.39

Chimin Health Management Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															9.81	2.64	2.79	-21.22	5.04

Chimin Health Management Co ROCE % Calculation

Chimin Health Management Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-28.76	/	( ( (2714.077 - 584.083)	+	(2479.979 - 469.032) )	/ 2 )
	=	-28.76	/	( (2129.994	+	2010.947)	/ 2 )
	=	-28.76	/	2070.4705
	=	-1.39 %

Chimin Health Management Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	101.168	/	( ( (2479.979 - 469.032)	+	(2520.848 - 515.796) )	/ 2 )
	=	101.168	/	( ( 2010.947	+	2005.052 )	/ 2 )
	=	101.168	/	2007.9995
	=	5.04 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Chimin Health Management Co (SHSE:603222) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Chimin Health Management Co ROCE % Related Terms

Thank you for viewing the detailed overview of Chimin Health Management Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Chimin Health Management Co (SHSE:603222) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Chimin Health Management Co Ltd (SHSE:603222) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 888, Beiyuan Road, Huangyan District, Zhejiang Province, Taizhou, CHN, 318020

Website

http://www.chimin.cn

Chimin Health Management Co Ltd is engaged in the pharmaceutical industry. It is engaged in the research and development, production and sales of human medicines and medical devices. Its product centers include large volume injection, medical instruments, Nephrology treatment, and medical service. The company has production bases in Taizhou, Shanghai and Spain.

Chimin Health Management Co (SHSE:603222) Headlines

No Headlines